Scientific Industries, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCND research report →
Price Chart
About the company
Scientific Industries, Inc. operates as a global enterprise specializing in the development, production, and distribution of a comprehensive range of benchtop laboratory instrumentation and advanced bioprocessing systems. Their product line features an assortment of mixers and shakers, prominently including vortex mixers designed to efficiently blend the contents of test tubes, beakers, and similar containers by utilizing a rotating cup or alternative attachments.
- CEO
- Helena R. Santos
- IPO
- 1994
- Employees
- 55
- HQ
- Bohemia, NY, US
Get TickerSpark's AI analysis on SCND
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.29M
- P/E
- -1.74
- PEG
- 0.00
- P/S
- 1.28
- P/B
- 0.84
- EV/EBITDA
- -0.59
- Div Yield
- 0.00%
- Gross Margin
- 31.27%
- Op Margin
- -111.22%
- Net Margin
- -75.13%
- ROE
- -46.73%
- ROIC
- -63.93%
Latest fiscal year · YoY change
- Revenue
- $5.05M-52.8%
- Gross Profit
- $1.30M-72.5%
- Op Income
- $-7,598,300
- Net Income
- $-1,220,400+81.1%
- EPS
- $-0.11+82.0%
- OCF Growth
- -121.2%
- FCF Growth
- -117.1%
- 52W High
- $0.88
- 52W Low
- $0.30
- 50D MA
- $0.68
- 200D MA
- $0.69
- Beta
- 0.28
- RSI (14)
- 48
- Avg Volume
- 2.81K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Scientific Industries said Q1 was a transition quarter: legacy sales grew strongly, the DOTS launch moved into shipping after quarter end, and management highlighted major cost cuts to support a path to profitability.· May 16, 2024
- Legacy SBI products drove sales growth of over 40% year over year, while new DOTS multi-parameter sensor shipments began after quarter end in April.
- The company secured $7 million in financing and used the quarter to finish development and launch the SBI DOTS platform.
- Management said it rightsized headcount and implemented broader cost actions, including voluntary pay cuts and stock-option swaps, to preserve cash.
- Early customer response to the new sensor was positive, with the first three orders shipped to high-profile clients and a growing pipeline from trade shows.
- Management expects the VIVID workstation launch and broader trade-show activity to support growth later in the year.
The company did not report consolidated revenue, EPS, or gross margin in the prepared remarks, but management said SBI sales grew by over 40% year over year, driven by legacy CGQ and liquid injection products because DOTS shipments started only after quarter end. John Moore said the legacy CGQ products enabled the company to sell inventory at an average gross margin of around 63%. The quarter included $7 million in financing, and management said it created a larger pipeline of over $3.5 million and more than 200 new leads in Q1. For guidance, management expects multi-parameter sensor sales to significantly increase the customer base and hardware and recurring revenue opportunities in the second half of the year, with VIVID expected to resume aggressive growth later in the year.
Helena Santos framed the quarter as a foundational step in rebuilding Scientific Industries around both Torbal and SBI growth businesses. She emphasized that financing allowed the company to complete and launch DOTS, that customers were willing to place orders before shipment, and that the company is building beyond its existing cash-generating Genie line. Her tone was upbeat but disciplined, stressing organization rightsizing, operational efficiency, and cash preservation while new products ramp.
John Moore focused on the financial and operating setup behind the launch, saying the company secured $7 million in financing and made cost-efficiency moves including a 23% staffing reduction and a voluntary salary-cut program. He said 72% of the team opted to trade cash for stock options at a $2.50 strike price, and that the measures will save around $1.5 billion over the next 12 months. He also noted higher Q1 cash costs tied to severance, financing, and the DOTS launch, while citing an average gross margin of around 63% on legacy CGQ inventory sales.
In Q&A, analysts asked why customers bought the new multi-parameter sensor before seeing it, and management said the product addresses a real need for affordable monitoring and control versus manual sampling and contamination risk. They pointed to repeat business, large account expansion potential, and specific customer types including a major pharmaceutical company, a large yeast producer, and a strain engineering company. When asked about customer behavior and competition, management said budget cycles and prior awareness from trade shows were now converting into demos and orders, and argued the bioprocessing tools market lacks innovation, which gives Scientific Industries a technological and IP advantage.
The positive case is that the new DOTS platform is now shipped and already validated by early customer orders, while the company has built a larger pipeline through trade shows and marketing. Management is also pointing to strong legacy growth, recurring-revenue potential from software subscriptions, and meaningful cost reductions that they believe will improve margins and the path to profitability.
The main risks are that the quarter did not include reported consolidated revenue or profit figures, and the company still has to convert the new pipeline into sustained sales. Management acknowledged higher Q1 cash costs from severance, financing, and launch expenses, and much of the growth story depends on execution in the second half of the year and the success of the new product rollout.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 49.9%
- Shares Outstanding
- 11.93M
- Float Shares
- 5.96M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 5, 26 | MOORE JOHN A | buy | 10,000 |
| Oct 31, 26 | MOORE JOHN A | buy | 7,100 |
| Oct 31, 26 | MOORE JOHN A | buy | 51,200 |
| Aug 20, 26 | MOORE JOHN A | buy | 5,000 |
| Aug 20, 26 | MOORE JOHN A | buy | 14,700 |
| Jun 2, 26 | MOORE JOHN A | buy | 4,000 |
| Feb 17, 26 | SANTOS HELENA R | other | 130,000 |
| Feb 17, 26 | SANTOS HELENA R | other | 50,000 |
| Mar 23, 26 | MOORE JOHN A | buy | 9,000 |
| Feb 17, 26 | Rovinsky Zachary | other | 25,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SCND coverage
Recent articles, reports, and earnings notes.
No research on SCND yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCND report →Scientific Industries (OTCMKTS:SCND) and TT Electronics (OTCMKTS:TTGPF) Critical Contrast
defenseworld.net · Aug 21
Scientific Industries, Inc. (SCND) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Jan 22
Scientific Industries, Inc. (SCND) Q3 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Nov 20
Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature
globenewswire.com · Nov 19
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
globenewswire.com · Nov 19
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
globenewswire.com · Sep 18
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
globenewswire.com · Aug 19
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
globenewswire.com · Aug 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.